An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University and other 7 well-known
hospitals in China. In order to report the efficacy and safety of different dose
dexamethasone in treating the immune thrombocytopenia (ITP).
Phase:
Phase 2
Details
Lead Sponsor:
Shandong University
Collaborators:
Anhui Provincial Hospital Chinese Academy of Medical Sciences Peking Union Medical College Hospital Second Hospital of Shanxi Medical University Shandong Provincial Hospital Shandong University of Traditional Chinese Medicine The First Affiliated Hospital of Dalian Medical University